The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cardiac Markers Testing Analyzer Market Research Report 2024
Synopsis
Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.
Global Cardiac Markers Testing Analyzer market is projected to reach US$ 352.2 million in 2029, increasing from US$ 240 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cardiac Markers Testing Analyzer market research.
The increasing adoption of sensitivity and premium-priced POC Troponin tests is contributing to the growth of the global market. The growing move towards value-based and efficient healthcare service delivery against the backdrop of stringent budgets is boosting the prospects for POC Cardiac testing market. Moreover, the majority of medical professionals opt of POC cardiac testing to quickly monitor the condition of patients experiencing chest pain or other heart ailment symptoms in emergency care environments. The global phenomenon of the burgeoning aging populace is driving demand for POC test kits for use in home healthcare and old age homes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cardiac Markers Testing Analyzer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Quidel
Abbott Laboratories
Roche
Danaher
Siemens Healthineers
LSI Medience
CardioGenics
Trinity Biotech
Boditech
Lifesign
Response Biomedical
Segment by Type
Desktop
Portable
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Cardiac Markers Testing Analyzer report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Cardiac Markers Analyzers usually measure the levels of enzymes and proteins released from heart muscle when it is damaged. Physicians use cardiac markers in two ways to diagnose a cardiac event in a hospital emergency room or within the hospital or to evaluate a risk of a cardiovascular event occurring.
Global Cardiac Markers Testing Analyzer market is projected to reach US$ 352.2 million in 2029, increasing from US$ 240 million in 2022, with the CAGR of 5.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Cardiac Markers Testing Analyzer market research.
The increasing adoption of sensitivity and premium-priced POC Troponin tests is contributing to the growth of the global market. The growing move towards value-based and efficient healthcare service delivery against the backdrop of stringent budgets is boosting the prospects for POC Cardiac testing market. Moreover, the majority of medical professionals opt of POC cardiac testing to quickly monitor the condition of patients experiencing chest pain or other heart ailment symptoms in emergency care environments. The global phenomenon of the burgeoning aging populace is driving demand for POC test kits for use in home healthcare and old age homes.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Cardiac Markers Testing Analyzer market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Quidel
Abbott Laboratories
Roche
Danaher
Siemens Healthineers
LSI Medience
CardioGenics
Trinity Biotech
Boditech
Lifesign
Response Biomedical
Segment by Type
Desktop
Portable
Segment by Application
Hospitals
Clinics
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Cardiac Markers Testing Analyzer report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Cardiac Markers Testing Analyzer Market Overview
1.1 Product Overview and Scope of Cardiac Markers Testing Analyzer
1.2 Cardiac Markers Testing Analyzer Segment by Type
1.2.1 Global Cardiac Markers Testing Analyzer Market Value Comparison by Type (2023-2029)
1.2.2 Desktop
1.2.3 Portable
1.3 Cardiac Markers Testing Analyzer Segment by Application
1.3.1 Global Cardiac Markers Testing Analyzer Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Cardiac Markers Testing Analyzer Market Size Estimates and Forecasts
1.4.1 Global Cardiac Markers Testing Analyzer Revenue 2018-2029
1.4.2 Global Cardiac Markers Testing Analyzer Sales 2018-2029
1.4.3 Global Cardiac Markers Testing Analyzer Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Cardiac Markers Testing Analyzer Market Competition by Manufacturers
2.1 Global Cardiac Markers Testing Analyzer Sales Market Share by Manufacturers (2018-2023)
2.2 Global Cardiac Markers Testing Analyzer Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Cardiac Markers Testing Analyzer Average Price by Manufacturers (2018-2023)
2.4 Global Cardiac Markers Testing Analyzer Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Cardiac Markers Testing Analyzer, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiac Markers Testing Analyzer, Product Type & Application
2.7 Cardiac Markers Testing Analyzer Market Competitive Situation and Trends
2.7.1 Cardiac Markers Testing Analyzer Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cardiac Markers Testing Analyzer Players Market Share by Revenue
2.7.3 Global Cardiac Markers Testing Analyzer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cardiac Markers Testing Analyzer Retrospective Market Scenario by Region
3.1 Global Cardiac Markers Testing Analyzer Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Cardiac Markers Testing Analyzer Global Cardiac Markers Testing Analyzer Sales by Region: 2018-2029
3.2.1 Global Cardiac Markers Testing Analyzer Sales by Region: 2018-2023
3.2.2 Global Cardiac Markers Testing Analyzer Sales by Region: 2024-2029
3.3 Global Cardiac Markers Testing Analyzer Global Cardiac Markers Testing Analyzer Revenue by Region: 2018-2029
3.3.1 Global Cardiac Markers Testing Analyzer Revenue by Region: 2018-2023
3.3.2 Global Cardiac Markers Testing Analyzer Revenue by Region: 2024-2029
3.4 North America Cardiac Markers Testing Analyzer Market Facts & Figures by Country
3.4.1 North America Cardiac Markers Testing Analyzer Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Cardiac Markers Testing Analyzer Sales by Country (2018-2029)
3.4.3 North America Cardiac Markers Testing Analyzer Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cardiac Markers Testing Analyzer Market Facts & Figures by Country
3.5.1 Europe Cardiac Markers Testing Analyzer Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Cardiac Markers Testing Analyzer Sales by Country (2018-2029)
3.5.3 Europe Cardiac Markers Testing Analyzer Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiac Markers Testing Analyzer Market Facts & Figures by Country
3.6.1 Asia Pacific Cardiac Markers Testing Analyzer Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Cardiac Markers Testing Analyzer Sales by Country (2018-2029)
3.6.3 Asia Pacific Cardiac Markers Testing Analyzer Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cardiac Markers Testing Analyzer Market Facts & Figures by Country
3.7.1 Latin America Cardiac Markers Testing Analyzer Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Cardiac Markers Testing Analyzer Sales by Country (2018-2029)
3.7.3 Latin America Cardiac Markers Testing Analyzer Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiac Markers Testing Analyzer Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiac Markers Testing Analyzer Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Cardiac Markers Testing Analyzer Sales by Country (2018-2029)
3.8.3 Middle East and Africa Cardiac Markers Testing Analyzer Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardiac Markers Testing Analyzer Sales by Type (2018-2029)
4.1.1 Global Cardiac Markers Testing Analyzer Sales by Type (2018-2023)
4.1.2 Global Cardiac Markers Testing Analyzer Sales by Type (2024-2029)
4.1.3 Global Cardiac Markers Testing Analyzer Sales Market Share by Type (2018-2029)
4.2 Global Cardiac Markers Testing Analyzer Revenue by Type (2018-2029)
4.2.1 Global Cardiac Markers Testing Analyzer Revenue by Type (2018-2023)
4.2.2 Global Cardiac Markers Testing Analyzer Revenue by Type (2024-2029)
4.2.3 Global Cardiac Markers Testing Analyzer Revenue Market Share by Type (2018-2029)
4.3 Global Cardiac Markers Testing Analyzer Price by Type (2018-2029)
5 Segment by Application
5.1 Global Cardiac Markers Testing Analyzer Sales by Application (2018-2029)
5.1.1 Global Cardiac Markers Testing Analyzer Sales by Application (2018-2023)
5.1.2 Global Cardiac Markers Testing Analyzer Sales by Application (2024-2029)
5.1.3 Global Cardiac Markers Testing Analyzer Sales Market Share by Application (2018-2029)
5.2 Global Cardiac Markers Testing Analyzer Revenue by Application (2018-2029)
5.2.1 Global Cardiac Markers Testing Analyzer Revenue by Application (2018-2023)
5.2.2 Global Cardiac Markers Testing Analyzer Revenue by Application (2024-2029)
5.2.3 Global Cardiac Markers Testing Analyzer Revenue Market Share by Application (2018-2029)
5.3 Global Cardiac Markers Testing Analyzer Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Quidel
6.1.1 Quidel Corporation Information
6.1.2 Quidel Description and Business Overview
6.1.3 Quidel Cardiac Markers Testing Analyzer Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Quidel Cardiac Markers Testing Analyzer Product Portfolio
6.1.5 Quidel Recent Developments/Updates
6.2 Abbott Laboratories
6.2.1 Abbott Laboratories Corporation Information
6.2.2 Abbott Laboratories Description and Business Overview
6.2.3 Abbott Laboratories Cardiac Markers Testing Analyzer Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Abbott Laboratories Cardiac Markers Testing Analyzer Product Portfolio
6.2.5 Abbott Laboratories Recent Developments/Updates
6.3 Roche
6.3.1 Roche Corporation Information
6.3.2 Roche Description and Business Overview
6.3.3 Roche Cardiac Markers Testing Analyzer Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Roche Cardiac Markers Testing Analyzer Product Portfolio
6.3.5 Roche Recent Developments/Updates
6.4 Danaher
6.4.1 Danaher Corporation Information
6.4.2 Danaher Description and Business Overview
6.4.3 Danaher Cardiac Markers Testing Analyzer Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Danaher Cardiac Markers Testing Analyzer Product Portfolio
6.4.5 Danaher Recent Developments/Updates
6.5 Siemens Healthineers
6.5.1 Siemens Healthineers Corporation Information
6.5.2 Siemens Healthineers Description and Business Overview
6.5.3 Siemens Healthineers Cardiac Markers Testing Analyzer Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Siemens Healthineers Cardiac Markers Testing Analyzer Product Portfolio
6.5.5 Siemens Healthineers Recent Developments/Updates
6.6 LSI Medience
6.6.1 LSI Medience Corporation Information
6.6.2 LSI Medience Description and Business Overview
6.6.3 LSI Medience Cardiac Markers Testing Analyzer Sales, Revenue and Gross Margin (2018-2023)
6.6.4 LSI Medience Cardiac Markers Testing Analyzer Product Portfolio
6.6.5 LSI Medience Recent Developments/Updates
6.7 CardioGenics
6.6.1 CardioGenics Corporation Information
6.6.2 CardioGenics Description and Business Overview
6.6.3 CardioGenics Cardiac Markers Testing Analyzer Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CardioGenics Cardiac Markers Testing Analyzer Product Portfolio
6.7.5 CardioGenics Recent Developments/Updates
6.8 Trinity Biotech
6.8.1 Trinity Biotech Corporation Information
6.8.2 Trinity Biotech Description and Business Overview
6.8.3 Trinity Biotech Cardiac Markers Testing Analyzer Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Trinity Biotech Cardiac Markers Testing Analyzer Product Portfolio
6.8.5 Trinity Biotech Recent Developments/Updates
6.9 Boditech
6.9.1 Boditech Corporation Information
6.9.2 Boditech Description and Business Overview
6.9.3 Boditech Cardiac Markers Testing Analyzer Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Boditech Cardiac Markers Testing Analyzer Product Portfolio
6.9.5 Boditech Recent Developments/Updates
6.10 Lifesign
6.10.1 Lifesign Corporation Information
6.10.2 Lifesign Description and Business Overview
6.10.3 Lifesign Cardiac Markers Testing Analyzer Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Lifesign Cardiac Markers Testing Analyzer Product Portfolio
6.10.5 Lifesign Recent Developments/Updates
6.11 Response Biomedical
6.11.1 Response Biomedical Corporation Information
6.11.2 Response Biomedical Cardiac Markers Testing Analyzer Description and Business Overview
6.11.3 Response Biomedical Cardiac Markers Testing Analyzer Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Response Biomedical Cardiac Markers Testing Analyzer Product Portfolio
6.11.5 Response Biomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiac Markers Testing Analyzer Industry Chain Analysis
7.2 Cardiac Markers Testing Analyzer Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiac Markers Testing Analyzer Production Mode & Process
7.4 Cardiac Markers Testing Analyzer Sales and Marketing
7.4.1 Cardiac Markers Testing Analyzer Sales Channels
7.4.2 Cardiac Markers Testing Analyzer Distributors
7.5 Cardiac Markers Testing Analyzer Customers
8 Cardiac Markers Testing Analyzer Market Dynamics
8.1 Cardiac Markers Testing Analyzer Industry Trends
8.2 Cardiac Markers Testing Analyzer Market Drivers
8.3 Cardiac Markers Testing Analyzer Market Challenges
8.4 Cardiac Markers Testing Analyzer Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
